GL1X · GenesisL1 explorer

MolNFT v1 · #144728 · protein

Crystal structure of HCV NS3/4A protease variant Y56H in complex with danoprevir

6C2O · NS3 protease: “Crystal structure of HCV NS3/4A protease variant Y56H in complex with danoprevir”. X-ray diffraction, 2 ligands (TSV, ZN), 2 pockets (best druggability 0.42). MolNFT v1 #144728 on GenesisL1: 3D structure, binding…

PDB
6C2O
Type
protein
Length
198 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NS3 protease
UniProt
C1KIK8
Ligands
TSV, ZN
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANS3 proteaseprotein19814% helix, 44% strandC1KIK8

Ligands and binding sites

  • TSV · (2R,6S,12Z,13aS,14aR,16aS)-6-[(tert-butoxycarbonyl)amino]-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8 ,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoro-2H-isoindole-2-carboxylate · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1550.420.8216empty
2690.330.7516empty

Compared structures

  • 6C2O · Crystal structure of HCV NS3/4A protease variant Y56H in complex with danoprevir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.